David S. Fink, PhD

David Fink, PhD, MPH is a social epidemiologist whose research applies a multi-level life course perspective, coupled with rigorous causal inference methodologies, to understand the causes of addiction and mental illness and estimate the effects of policies and programs. His research in mental health, substance use, and health policy are united by a desire to understand and address structural, societal, and interpersonal factors that shape health and well-being over the life course. He received his Masters in Public Health in epidemiology and biostatistics from San Diego State University and his PhD from Columbia University where his research focused on understanding the effects of cannabis legalization and prescription drug monitoring programs on drug-related morbidity and mortality. He is currently an assistant professor in Department of Internal Medicine at Yale, where he is funded by NIDA to investigate the effects of more flexible telehealth guidelines for buprenorphine prescribing for opioid use disorder.